The LAMEA dermal fillers market is estimated to grow at a CAGR of 7.4% during the forecast period. RoW countries include Brazil, Mexico and Colombia, Saudi Arabia and the United Arab Emirates (UAE).   RoW dermal fillers market is estimated to grow significantly during the forecast period owing to the rising demand for non-surgical procedures coupled with the rising availability of filler options available in the Brazilian market. As a result, the companies are looking to expand the availability of their dermal fillers in these countries. For instance, in January 2018, Sinclair Pharma plc announced that it has received regulatory approval of Ellansé by ANVISA in Brazil. Brazil is considered as one of the major aesthetic dermatology markets with a considerable rise in the injectable procedures reported in 2017.

This is representing a significant demand for non-surgical cosmetic procedures in these countries. For instance, as per ISAPS, in Brazil, the number of injectable procedures was 677,765 in 2017, whereas, in Columbia, it was 125,350 in 2017. Due to such a rise in injectable procedures, a significant availability of plastic surgeons has been witnessed in 2017. For instance, as per the ISAPS, in 2017, the estimated number of plastic surgeons in Brazil was 5,500, while, the estimated number of plastic surgeons in Colombia was 1,000. The demand for this injectable procedure is anticipated to grow significantly in the region coupled with increasing disposable income across the countries, such as Saudi Arabia and UAE, which in turn, will likely drive the demand for dermal filler treatment in the region.

 The LAMEA dermal fillers market can be segmented based on application, type, and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on type, the market is segmented into collagen fillers, poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and others. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development. 

Key players operating in the LAMEA dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market. For instance, in November 2018, Galderma Laboratories, L.P. received an FDA approval for ‘Restylane Lyft’, a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies. 

Research Methodology 

The market study of the LAMEA dermal fillers market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.

The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. LAMEA Dermal Fillers Market Research and Analysis by Application

2. LAMEA Dermal Fillers Market Research and Analysis by Type

3. LAMEA Dermal Fillers Market Research and Analysis by End-User

The Report Covers:

• Comprehensive research methodology of the LAMEA dermal fillers market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the LAMEA dermal fillers market.
• Insights about market determinants which are stimulating the LAMEA dermal fillers market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.